Pranay Gupta, MD
Ophthalmology · Colonial Heights, VANPI 1982641049
Payments from drug & device makers
Across 54 payments — averaging $20.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$266
- Mallinckrodt Hospital Products Inc.$204
- Aerie Pharmaceuticals, Inc.$95
- Amgen$92
- Eyepoint US, Inc.$79
- Sun Pharmaceutical Industries Inc.$55
- plus $314 from 13 others
What the payments were for
- Food & beverage$1,105100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 13 | $266 |
| Mallinckrodt Hospital Products Inc. | 10 | $204 |
| Aerie Pharmaceuticals, Inc. | 1 | $95 |
| Amgen(2 entities) | 6 | $92 |
| Eyepoint US, Inc. | 1 | $79 |
| Sun Pharmaceutical Industries Inc. | 3 | $55 |
| Thea Pharma Inc. | 3 | $52 |
| AbbVie(2 entities) | 3 | $47 |
| Rxsight Inc | 1 | $44 |
| Biotissue Holdings Inc. | 2 | $33 |
| Ocular Therapeutix, Inc. | 1 | $23 |
| Bausch & Lomb Americas Inc. | 1 | $22 |
| Akorn Operating Company LLC | 1 | $20 |
| Astellas Pharma US Inc | 1 | $19 |
| Rayner Intraocular Lenses Limited | 1 | $15 |
| Oasis Medical, Inc. | 1 | $14 |
| Alimera Sciences, Inc. | 1 | $13 |
| Kala Pharmaceuticals, Inc. | 1 | $12 |
| Rapid Pathogen Screening, Inc. | 3 | $0 |
How this compares
$1,105 in reported general payments places this provider in the 50th percentile of 509 ophthalmology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 81 | $1,963 |
| Latanoprost | 221 | $1,835 |
| Prednisolone Acetate | 52 | $1,669 |
| Brimonidine Tartrate | 37 | $932 |
| Timolol Maleate | 121 | $572 |
| Dorzolamide Hcl | 29 | $506 |
| Atropine Sulfate | 19 | $503 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Colonial Heights
- James PaauwLynchburg$7M
- Golnaz JaveyLynchburg$6.7M
- Kapil KapoorNorfolk$4.3M
- Ali TabassianRichmond$2.1M
- Elizabeth Yeu-LinNorfolk$2M
- Ethnie JonesRichmond$2M
- Alan WagnerNorfolk$1.8M
- John SheppardNorfolk$1.2M
- Gustavo CorralesFalls Church$888K
- Frank CotterRoanoke$874K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.